PAVmed
PAVM
8 hedge funds and large institutions have $1.01M invested in PAVmed in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
97% more capital invested
Capital invested by funds: $512K → $1.01M (+$497K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
14% more funds holding
Funds holding: 7 → 8 (+1)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$63.2K |
| 2 |
LCS
Levin Capital Strategies
New York
|
+$25.6K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.6K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$10.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$17K |
| 2 |
Renaissance Technologies
New York
|
-$10K |
| 3 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$916 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $450K | +$15.6K | +34 | +4% |
|
|
2
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $399K | +$63.2K | +138 | New |
|
3
Geode Capital Management
Boston,
Massachusetts
| $77K | – | – | – |
|
|
LCS
4
Levin Capital Strategies
New York
| $27K | +$25.6K | +56 | New |
|
5
Northern Trust
Chicago,
Illinois
| $24K | – | – | – |
|
|
MSAM
6
Moloney Securities Asset Management
Manchester,
Missouri
| $13K | -$916 | -2 | -7% |
|
|
PAG
7
Private Advisor Group
Morristown,
New Jersey
| $11K | +$10.1K | +22 | New |
|
|
GWS
8
Glassman Wealth Services
Vienna,
Virginia
| $8K | – | – | – |
|
|
TSS
9
Two Sigma Securities
New York
| – | -$17K | -40 | Closed |
|
|
10
Renaissance Technologies
New York
| – | -$10K | -23 | Closed |
|
PAVM Hedge Fund Activity: Q1 2019 in Review
8 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2019, worth a combined $1.01M — up 97% from $512K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PAVM positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Carson Wealth (CWM LLC), opening a new position worth an estimated $63.2K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $17K sold.
- 8 institutional investors held PAVmed (PAVM) as of Q1 2019, up from 7 in Q4 2018.
- Funds reported $1.01M of PAVmed stock for Q1 2019, up 97% quarter-over-quarter.
- 3 funds opened new PAVmed positions in Q1 2019 and 2 closed out, a net change of +1 holder.
- The largest PAVmed buyer in Q1 2019 was Carson Wealth (CWM LLC), an estimated $63.2K added.
- The largest PAVmed seller in Q1 2019 was Two Sigma Securities, an estimated $17K sold.
Based on aggregated 13F filings for Q1 2019.